Effect of chlorphentermine pretreatment on chlorphentermine uptake by isolated perfused rat lung. 1982

L S Angevine, and Y Ohmiya, and H M Mehendale

Chlorphentermine (CP), an anorectic agent currently in use, is known to be highly accumulated in the lung, causes pulmonary phospholipidosis, and has been suspected of causing pulmonary hypertension. These studies were undertaken to characterize the uptake and accumulation processes and to examine the effect of subacute CP treatment on the uptake kinetics of CP in the rat lung. Animals were treated po with a saline solution of CP (50 mg/kg/day) for 7 days and the controls received the vehicle only. Artificially ventilated isolated rat lung preparations were perfused with Krebs-Ringer bicarbonate buffer containing bovine serum albumin. CP was not metabolized by control or pretreated perfused lungs or by their 9000g supernatant or microsomal fractions. In recirculating perfusion experiments, steady-state uptake was reached after 20 min of perfusion with 0.17 mM CP. Lungs from rats treated with CP as described above accumulated CP to a greater extent and more rapidly than did lungs from control rats. Similarly, lungs from rats treated with CP accumulated significantly greater quantities of CP than control lungs during single-pass perfusion experiments. Whereas control lungs reached a steady state uptake within 7 min, lungs from CP treated animals failed to reach a steady-state uptake during a 10-min perfusion. The lungs from CP-treated rats retained most of the accumulated CP and exhibited a significantly increased half life of efflux in comparison to control rats. Removal of Na+ from the perfusion medium or the addition of harmaline significantly decreased the half-life of CP uptake and the amount of CP accumulated by the lung.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010645 Phentermine A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity. Adipex-P,Duromine,Ionamine,Phentermine Hydrochloride,Adipex P,AdipexP,Hydrochloride, Phentermine
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D002745 Chlorphentermine A sympathomimetic agent that was formerly used as an anorectic. It has properties similar to those of DEXTROAMPHETAMINE. It has been implicated in lipid storage disorders and pulmonary hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1223) Avipron,Chlorphentermine Hydrochloride,Desopimon,Pre-Sate,Hydrochloride, Chlorphentermine
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006246 Harmaline A beta-carboline alkaloid isolated from seeds of PEGANUM. 3H-Pyrido(3,4-b)indole, 4,9-dihydro-7-methoxy-1-methyl-,Dihydroharmine,Harmidine
D000042 Absorption The physical or physiological processes by which substances, tissue, cells, etc. take up or take in other substances or energy.

Related Publications

L S Angevine, and Y Ohmiya, and H M Mehendale
February 1980, Toxicology and applied pharmacology,
L S Angevine, and Y Ohmiya, and H M Mehendale
April 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology,
L S Angevine, and Y Ohmiya, and H M Mehendale
January 1982, Fundamental and applied toxicology : official journal of the Society of Toxicology,
L S Angevine, and Y Ohmiya, and H M Mehendale
January 1981, European journal of drug metabolism and pharmacokinetics,
L S Angevine, and Y Ohmiya, and H M Mehendale
December 1979, The Journal of pharmacology and experimental therapeutics,
L S Angevine, and Y Ohmiya, and H M Mehendale
December 1978, Research communications in chemical pathology and pharmacology,
L S Angevine, and Y Ohmiya, and H M Mehendale
May 1981, Experimental lung research,
L S Angevine, and Y Ohmiya, and H M Mehendale
February 1971, British journal of pharmacology,
L S Angevine, and Y Ohmiya, and H M Mehendale
December 1980, The American review of respiratory disease,
L S Angevine, and Y Ohmiya, and H M Mehendale
October 1988, Biochemical pharmacology,
Copied contents to your clipboard!